Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Mississippi River and sea surface height effects on oil slick migration.

Falcini F, Jerolmack DJ, Nardelli BB.

PLoS One. 2012;7(4):e36037. doi: 10.1371/journal.pone.0036037. Epub 2012 Apr 27.

2.

Value-of-information analysis to guide future research in the management of the colorectal malignant polyp.

Hassan C, Pickhardt PJ, Di Giulio E, Hunink MG, Zullo A, Nardelli BB.

Dis Colon Rectum. 2010 Feb;53(2):135-42. doi: 10.1007/DCR.0b013e3181c3be55.

PMID:
20087087
3.

High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma.

Tecchio C, Nadali G, Scapini P, Bonetto C, Visco C, Tamassia N, Vassilakopoulos TP, Pangalis GA, Calzetti F, Nardelli B, Roschke V, Gottardi M, Zampieri F, Gherlinzoni F, Facchetti F, Pizzolo G, Cassatella MA.

Br J Haematol. 2007 Jun;137(6):553-9.

PMID:
17539776
4.

Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis.

Cassatella MA, Pereira-da-Silva G, Tinazzi I, Facchetti F, Scapini P, Calzetti F, Tamassia N, Wei P, Nardelli B, Roschke V, Vecchi A, Mantovani A, Bambara LM, Edwards SW, Carletto A.

J Immunol. 2007 Jun 1;178(11):7325-33. Erratum in: J Immunol. 2007 Jul 15;179(2):1390. da Silva, Gabriela Pereira [corrected to Pereira-da-Silva, Gabriela].

5.

Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis.

Scarponi C, Nardelli B, Lafleur DW, Moore PA, Madonna S, De Pità O, Girolomoni G, Albanesi C.

J Interferon Cytokine Res. 2006 Mar;26(3):133-40.

PMID:
16542135
6.

Osteostat/tumor necrosis factor superfamily 18 inhibits osteoclastogenesis and is selectively expressed by vascular endothelial cells.

Nardelli B, Zaritskaya L, McAuliffe W, Ni Y, Lincoln C, Cho YH, Birse CE, Halpern W, Ullrich S, Moore PA.

Endocrinology. 2006 Jan;147(1):70-8. Epub 2005 Sep 22.

PMID:
16179414
7.

Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases.

Scapini P, Carletto A, Nardelli B, Calzetti F, Roschke V, Merigo F, Tamassia N, Pieropan S, Biasi D, Sbarbati A, Sozzani S, Bambara L, Cassatella MA.

Blood. 2005 Jan 15;105(2):830-7. Epub 2004 Sep 9.

PMID:
15358625
8.
9.

An IFN-beta-albumin fusion protein that displays improved pharmacokinetic and pharmacodynamic properties in nonhuman primates.

Sung C, Nardelli B, LaFleur DW, Blatter E, Corcoran M, Olsen HS, Birse CE, Pickeral OK, Zhang J, Shah D, Moody G, Gentz S, Beebe L, Moore PA.

J Interferon Cytokine Res. 2003 Jan;23(1):25-36.

PMID:
12639296
10.

G-CSF-stimulated neutrophils are a prominent source of functional BLyS.

Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C, Cassatella MA.

J Exp Med. 2003 Feb 3;197(3):297-302.

11.

Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system.

Nardelli B, Zaritskaya L, Semenuk M, Cho YH, LaFleur DW, Shah D, Ullrich S, Girolomoni G, Albanesi C, Moore PA.

J Immunol. 2002 Nov 1;169(9):4822-30.

12.

B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.

Nardelli B, Moore PA, Li Y, Hilbert DM.

Leuk Lymphoma. 2002 Jul;43(7):1367-73. Review.

PMID:
12389615
13.

Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.

Osborn BL, Olsen HS, Nardelli B, Murray JH, Zhou JX, Garcia A, Moody G, Zaritskaya LS, Sung C.

J Pharmacol Exp Ther. 2002 Nov;303(2):540-8.

PMID:
12388634
14.

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.

Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V, Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS.

J Immunol. 2002 Oct 15;169(8):4314-21.

15.

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL.

Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A.

Nat Immunol. 2002 Sep;3(9):822-9. Epub 2002 Aug 5.

16.

Interferon-kappa, a novel type I interferon expressed in human keratinocytes.

LaFleur DW, Nardelli B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, Chen G, Ruben SM, Pitha PM, Coleman TA, Moore PA.

J Biol Chem. 2001 Oct 26;276(43):39765-71. Epub 2001 Aug 20.

17.

Analysis of eosinophils and myeloid progenitor responses to modified forms of MPIF-2.

Grzegorzewski KJ, Yao XT, Kreider B, Olsen HS, Morris TS, Zhang L, Sanyal I, Nardelli B, Zukauskas D, Brewer L, Bong GW, Kim Y, Garotta G, Salcedo TW.

Cytokine. 2001 Feb 21;13(4):209-19.

PMID:
11237428
18.

BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1.

Kanakaraj P, Migone TS, Nardelli B, Ullrich S, Li Y, Olsen HS, Salcedo TW, Kaufman T, Cochrane E, Gan Y, Hilbert DM, Giri J.

Cytokine. 2001 Jan 7;13(1):25-31.

PMID:
11145839
19.

Synthesis and release of B-lymphocyte stimulator from myeloid cells.

Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM.

Blood. 2001 Jan 1;97(1):198-204.

PMID:
11133761
20.

Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS.

Wu Y, Bressette D, Carrell JA, Kaufman T, Feng P, Taylor K, Gan Y, Cho YH, Garcia AD, Gollatz E, Dimke D, LaFleur D, Migone TS, Nardelli B, Wei P, Ruben SM, Ullrich SJ, Olsen HS, Kanakaraj P, Moore PA, Baker KP.

J Biol Chem. 2000 Nov 10;275(45):35478-85.

21.

Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.

Giovarelli M, Cappello P, Forni G, Salcedo T, Moore PA, LeFleur DW, Nardelli B, Di Carlo E, Lollini PL, Ruben S, Ullrich S, Garotta G, Musiani P.

J Immunol. 2000 Mar 15;164(6):3200-6.

22.

C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.

Nibbs RJ, Salcedo TW, Campbell JD, Yao XT, Li Y, Nardelli B, Olsen HS, Morris TS, Proudfoot AE, Patel VP, Graham GJ.

J Immunol. 2000 Feb 1;164(3):1488-97.

23.

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM.

Science. 1999 Jul 9;285(5425):260-3.

24.

Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-gamma and CD40 ligation.

Nardelli B, Morahan DK, Bong GW, Semenuk MA, Kreider BL, Garotta G.

J Leukoc Biol. 1999 Jun;65(6):822-8.

PMID:
10380905
25.

Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.

Nardelli B, Tiffany HL, Bong GW, Yourey PA, Morahan DK, Li Y, Murphy PM, Alderson RF.

J Immunol. 1999 Jan 1;162(1):435-44.

26.

Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors.

Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G.

J Exp Med. 1997 Apr 7;185(7):1163-72.

27.

CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells.

Nardelli B, Gonzalez CJ, Schechter M, Valentine FT.

Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7312-6.

28.

The MAP system. A flexible and unambiguous vaccine design of branched peptides.

Nardelli B, Tam JP.

Pharm Biotechnol. 1995;6:803-19. Review. No abstract available.

PMID:
7551249
30.

Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.

Huang W, Nardelli B, Tam JP.

Mol Immunol. 1994 Oct;31(15):1191-9.

PMID:
7935506
31.

Production of linear polymers of HIV gp120-binding domains.

Smythe JA, Nardelli B, Chatterjee P, Gallo RC, Gershoni JM.

Protein Eng. 1994 Feb;7(2):145-7.

PMID:
8170917
33.

A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity.

Defoort JP, Nardelli B, Huang W, Tam JP.

Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):214-21.

PMID:
1478779
34.

Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant.

Nardelli B, Defoort JP, Huang W, Tam JP.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1405-7. No abstract available.

PMID:
1466968
35.

Macromolecular assemblage in the design of a synthetic AIDS vaccine.

Defoort JP, Nardelli B, Huang W, Ho DD, Tam JP.

Proc Natl Acad Sci U S A. 1992 May 1;89(9):3879-83.

36.

A chemically defined synthetic vaccine model for HIV-1.

Nardelli B, Lu YA, Shiu DR, Delpierre-Defoort C, Profy AT, Tam JP.

J Immunol. 1992 Feb 1;148(3):914-20.

PMID:
1370524
37.

Genomic aspects of drug-induced xenogenization of murine tumors.

Fuschiotti P, Grohmann U, Allegrucci M, Nardelli B, Fioretti MC.

Pharmacol Res. 1992 Feb-Mar;25 Suppl 1:19-20. No abstract available.

PMID:
1354858
38.
39.

Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant.

Romani L, Grohmann U, Puccetti P, Nardelli B, Mage MG, Fioretti MC.

Cell Immunol. 1988 Feb;111(2):365-78.

PMID:
3123072
40.

Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations.

Romani L, Nardelli B, Bianchi R, Puccetti P, Mage M, Fioretti MC.

Int J Cancer. 1985 May 15;35(5):659-65.

PMID:
3888855
41.

[Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models].

Bianchi R, Nardelli B, Allegrucci M, Fioretti MC.

G Ital Chemioter. 1985 Jan-Apr;32(1):1-6. Italian. No abstract available.

PMID:
3830770
42.

Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.

Nardelli B, Puccetti P, Romani L, Sava G, Bonmassar E, Fioretti MC.

Cancer Immunol Immunother. 1984;17(3):213-7.

PMID:
6566603
43.

Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.

Nardelli B, Contessa AR, Romani L, Sava G, Nisi C, Fioretti MC.

Cancer Immunol Immunother. 1984;16(3):157-61.

PMID:
6561067
44.

Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests.

Rivosecchi Merletti P, Bianchi R, Nardelli B, Iorio AM, Campanile F, Migliorati G, Bonmassar E.

Int J Tissue React. 1983;5(1):19-27.

PMID:
6862787
45.

Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.

Romani L, Fioretti MC, Bianchi R, Nardelli B, Bonmassar E.

J Natl Cancer Inst. 1982 May;68(5):817-22.

PMID:
7040772
46.

Mouse brain: an immunologically privileged site for natural resistance against lymphoma cells.

Circolo A, Bianchi R, Nardelli B, Rivosecchi-Merletti P, Bonmassar E.

J Immunol. 1982 Feb;128(2):556-62. No abstract available.

PMID:
7054288
47.

[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule].

Circolo A, Bianchi R, Nardelli B, Romani L, Andrielli M.

Boll Soc Ital Biol Sper. 1979 Oct 15;55(19):1974-80. Italian.

PMID:
554636
48.

[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC].

Romani L, Bianchi R, Nardelli B, Circolo A, Andrielli M.

Boll Soc Ital Biol Sper. 1979 Oct 15;55(19):1981-7. Italian.

PMID:
317993

Supplemental Content

Loading ...
Support Center